Juva Life Inc (OTCMKTS:JUVAF) is a noted name in the life sciences space. At this point in time, the company is not only involved in cannabis production and distribution but also pharmaceutical development and research.
Market Stats
On Tuesday, JUVAF stock fell 7.37% to $0.2226 with more than 200k shares, compared to its average volume of 246k shares. The stock has moved within a range of $0.2220 – 0.2550 after opening trading at $0.2423.
Juva Life Expands WIRB-Approved Cannabis Patient Registry Study
Yesterday, the Juva Life stock was in the middle of a strong selloff after it made a key announcement with regards to its cannabis business and ended the day with a decline of as much as 7%. The company announced yesterday that it had launched the very first cannabis registry for the purposes of clinical research on how public health can be improved through the use of cannabis. The initiative from Juva Life is spread across the United States.
To that end, the company has launched the IMPACT Registry and it has been also been listed on clinicaltrials.gov. The scope of the project is immense and hence, it might be a good idea for investors to keep an eye on the developments over the coming months. The registry is looking to gather one of the world’s biggest pool of data with regards to clinical evidence that might show the health benefits that might be brought about by cannabis.
Traders Corner
JUVAF stock is trading below the 20-Day and 50-Day Moving averages of $0.25 and $0.27 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.47.
